These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 12042648)

  • 1. Improved flow cytometric detection of donor-specific HLA class II antibodies by heat inactivation.
    Ta M; Scornik JC
    Transplantation; 2002 May; 73(10):1611-4. PubMed ID: 12042648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Weak humoral posttransplant alloresponse after a well-HLA-matched cadaveric kidney transplantation.
    Matinlauri IH; Kyllönen LE; Eklund BH; Koskimies SA; Salmela KT
    Transplantation; 2004 Jul; 78(2):198-204. PubMed ID: 15280678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flow cytometry crossmatching: a method for monitoring antidonor antibodies in heart transplant recipients.
    Hurley JP; Cook DJ; McCarthy PM; Hobbs RE; Koo AP; Ratliff NB; Klingman LL; Mrzena K; Stewart RW
    Transplant Proc; 1995 Feb; 27(1):1301-2. PubMed ID: 7878891
    [No Abstract]   [Full Text] [Related]  

  • 4. Positive B-cell only flow cytometric crossmatch: implications for renal transplantation.
    Delgado JC; Eckels DD
    Exp Mol Pathol; 2008 Aug; 85(1):59-63. PubMed ID: 18499103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved flow cytometric detection of HLA alloantibodies using pronase: potential implications in renal transplantation.
    Vaidya S; Cooper TY; Avandsalehi J; Barnes T; Brooks K; Hymel P; Noor M; Sellers R; Thomas A; Stewart D; Daller J; Fish JC; Gugliuzza KK; Bray RA
    Transplantation; 2001 Feb; 71(3):422-8. PubMed ID: 11233905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A retrospective flow cytometric crossmatch study in transplant recipients with autoreactive lymphocytotoxic antibodies.
    Martin S; Davies MS; Robson AJ
    Transpl Int; 1994; 7 Suppl 1():S527-31. PubMed ID: 11271299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new method for determining anti-B cell antibodies and their specificity using flow cytometry.
    Berteli AJ; Daniel V; Terness P; Opelz G
    J Immunol Methods; 1993 Aug; 164(1):21-5. PubMed ID: 8360506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The flow cytometric crossmatch. Dual-color analysis of T cell and B cell reactivities.
    Bray RA; Lebeck LK; Gebel HM
    Transplantation; 1989 Nov; 48(5):834-40. PubMed ID: 2815255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pronase independent flow cytometry crossmatching of rituximab treated patients.
    Alheim M; Wennberg L; Wikström AC
    Hum Immunol; 2018 Feb; 79(2):132-135. PubMed ID: 29157993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of donor-specific anti-HLA class I and II antibodies using antibody monitoring system.
    Yang CW; Oh EJ; Lee SB; Moon IS; Kim DG; Choi BS; Park SC; Choi YJ; Park YJ; Han K
    Transplant Proc; 2006 Nov; 38(9):2803-6. PubMed ID: 17112834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Falsely incompatible B-cell flow cytometry crossmatch after pronase treatment: a case report.
    Hart JD; Lutz CT; Jennings CD; May JR; Nelson K; Jacobs S; Hoopes CW
    Transplant Proc; 2015 Apr; 47(3):831-3. PubMed ID: 25891741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of magnetic beads coated with soluble HLA class I or class II proteins in antibody screening and for specificity determinations of donor-reactive antibodies.
    Sumitran-Karuppan S; Moller E
    Transplantation; 1996 May; 61(10):1539-45. PubMed ID: 8633385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequent false-positive reactions in pronase-treated T-cell flow cytometric cross-match tests.
    Park H; Lim YM; Han BY; Hyun J; Song EY; Park MH
    Transplant Proc; 2012 Jan; 44(1):87-90. PubMed ID: 22310587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specificity and Ig class of preformed alloantibodies causing a positive crossmatch in renal transplantation. The implications for graft survival.
    ten Hoor GM; Coopmans M; Allebes WA
    Transplantation; 1993 Aug; 56(2):298-304. PubMed ID: 7689256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of rituximab on the T-cell flow cytometric crossmatch.
    Doss SA; Mittal S; Daniel D
    Transpl Immunol; 2021 Feb; 64():101360. PubMed ID: 33359130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum flow cytometric C1q binding antibody analysis of renal recipients with low levels of sensitization.
    Ata P; Canbakan M; Kara M; Özel L; Ünal E; Titiz Mİ
    Transplant Proc; 2012; 44(6):1652-5. PubMed ID: 22841237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HLA Class II-specific antibodies can react with T cells in flow cytometry crossmatch: a case report.
    Heo WB; Kim CD; Won DI
    Transplant Proc; 2007 Dec; 39(10):3485-7. PubMed ID: 18089415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid optimized flow cytometric crossmatch (FCXM) assays: The Halifax and Halifaster protocols.
    Liwski RS; Greenshields AL; Conrad DM; Murphey C; Bray RA; Neumann J; Gebel HM
    Hum Immunol; 2018 Jan; 79(1):28-38. PubMed ID: 29109009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Flow cytometric evaluation of pregnancy-induced anti-donor immunization.
    Ayna TK; Ciftci HS; Tozkir H; Sagiroglu T; Isitmangil G; Gurtekin B; Gurtekin M
    Transplant Proc; 2012; 44(6):1656-9. PubMed ID: 22841238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of complement-fixing and non-fixing antibodies specific for endothelial precursor cells and lymphocytes using flow cytometry.
    AlMahri A; Holgersson J; Alheim M
    Tissue Antigens; 2012 Nov; 80(5):404-15. PubMed ID: 22931381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.